LISA WISCHHUSEN: Open Payments
NPI 1982645016 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 54 payments from 13 companies in 2025. Trend: 2023 $1,536 · 2024 $2,394 · 2025 $1,648
Food & beverage: $1,536Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $502 |
| Axsome Therapeutics, Inc. | 4 | $273 |
| E.R. Squibb & Sons, L.L.C. | 7 | $223 |
| ABBVIE INC. | 7 | $157 |
| Alkermes, Inc. | 2 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $139 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: Auvelity, COBENFY, AUSTEDO XR, UZEDY, VRAYLAR, CAPLYTA, ARISTADA, INGREZZA.
Industry payments across SC — which companies pay providers there.
